文献速递创伤与烧伤复苏、休克与脓毒症

创伤患者院前血浆输注与生存相关,主要见于钝性损伤:两项院前血浆随机试验结果

Prehospital plasma in injured patients is associated with survival principally in blunt injury: Results from two randomized prehospital plasma trials.
PubMed 文献 · J Trauma Acute Care Surg · 2020-01-01
一句话结论二次分析显示,院前血浆与钝性损伤患者28天死亡风险独立降低32%相关(HR 0.68),穿透性损伤患者无生存获益。

本研究对两项院前血浆随机试验的统一数据集进行二次分析,比较血浆组与对照组在钝性伤和穿透性伤患者中的院前时间、到达时休克参数、24小时输血需求及生存情况。钝性伤患者(n=465)分层Kaplan-Meier曲线显示显著分离(p=0.01),校正混杂因素后院前血浆与28天死亡独立风险降低32%相关(HR 0.68,95%CI 0.47-0.96,p=0.03);穿透性伤患者(n=161)无曲线分离(p=0.60),无独立生存获益(HR 1.16,95%CI 0.4-3.1,p=0.78)。穿透性伤中未显示血浆相关不良效应。作者认为该结果对军事和平民创伤系统有重要意义。

要点

  • 钝性损伤患者(n=465)院前血浆与28天死亡独立风险降低32%相关(HR 0.68,95%CI 0.47-0.96,p=0.03)。
  • 穿透性损伤患者(n=161)院前血浆无独立生存获益(HR 1.16,95%CI 0.4-3.1,p=0.78),分层Kaplan-Meier曲线无分离(p=0.60)。
  • 穿透性伤患者院前时间小于20分钟的比例显著高于钝性伤患者(28.0% vs 11.6%,p<0.01)。
  • 钝性伤患者损伤严重度更高、年龄更大、格拉斯哥昏迷评分更低;两组到达时休克指标和凝血参数相似。
  • 穿透性损伤中未显示可归因于血浆的不良效应;作者认为结果对军事和平民创伤系统有重要意义。

适用人群与场景

  • 来自两项院前血浆随机试验的统一数据集,纳入有失血性休克风险的创伤患者,按损伤机制分为钝性伤(n=465)和穿透性伤(n=161)。
  • 两项试验使用相同的纳入/排除标准和主要/次要结局。

研究设计与关键结果

  • 研究类型:两项院前血浆随机试验的统一数据集二次分析;钝性伤患者n=465,穿透性伤患者n=161。
  • 钝性伤患者分层Kaplan-Meier曲线显示显著分离(p=0.01);穿透性伤患者无分离(p=0.60)。
  • 校正所有重要混杂因素后,钝性伤患者院前血浆与28天死亡独立风险降低32%相关(HR 0.68,95%CI 0.47-0.96,p=0.03)。
  • 穿透性伤患者无独立生存获益(HR 1.16,95%CI 0.4-3.1,p=0.78)。
  • 穿透性伤患者院前时间小于20分钟的比例显著高于钝性伤患者(28.0% vs 11.6%,p<0.01)。
  • 钝性伤患者损伤严重度更高、年龄更大、格拉斯哥昏迷评分更低;到达时休克指标和凝血参数在钝性与穿透性伤之间相似。
  • 作者结论:院前血浆在24小时和28天的生存获益主要存在于钝性伤患者,穿透性伤患者无获益,也未显示血浆相关不良效应。

证据类型、等级与局限

  • 证据类型:两项随机试验数据的二次分析;证据等级:治疗性,I级。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者结论认为,院前血浆在24小时和28天的生存获益主要存在于钝性伤患者,穿透性伤患者无获益,也未显示血浆相关不良效应;作者认为该结果对军事和平民创伤系统有重要意义。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

INTRODUCTION: Recent evidence demonstrated that prehospital plasma in patients at risk of hemorrhagic shock was safe for ground transport and resulted in a 28-day survival benefit for air medical transport patients. Whether any beneficial effect of prehospital plasma varies across injury mechanism remains unknown.

METHODS: We performed a secondary analysis using a harmonized data set derived from two recent prehospital plasma randomized trials. Identical inclusion/exclusion criteria and primary/secondary outcomes were used for the trials. Prehospital time, arrival shock parameters, and 24-hour transfusion requirements were compared across plasma and control groups stratified by mechanism of injury. Stratified survival analysis and Cox hazard regression were performed to determine the independent survival benefits of plasma across blunt and penetrating injury.

RESULTS: Blunt patients had higher injury severity, were older, and had a lower Glasgow Coma Scale. Arrival indices of shock and coagulation parameters were similar across blunt and penetrating injury. The percentage of patients with a prehospital time less than 20 minutes was significantly higher for penetrating patients relative to blunt injured patients (28.0% vs. 11.6%, p < 0.01). Stratified Kaplan-Meier curves demonstrated a significant separation for blunt injured patients (n = 465, p = 0.01) with no separation demonstrated for penetrating injured patients (n = 161, p = 0.60) Stratified Cox hazard regression verified, after controlling for all important confounders, that prehospital plasma was associated with a 32% lower independent hazard for 28-day mortality in blunt injured patients (hazard ratio, 0.68; 95% confidence interval, 0.47-0.96; p = 0.03) with no independent survival benefit found in penetrating patients (hazard ratio, 1.16; 95% confidence interval, 0.4-3.1; p = 0.78).

CONCLUSION: A survival benefit associated with prehospital plasma at 24 hours and 28 days exists primarily in blunt injured patients with no benefit shown in penetrating trauma patients. No detrimental effects attributable to plasma are demonstrated in penetrating injury. These results have important relevance to military and civilian trauma systems.

LEVEL OF EVIDENCE: Therapeutic, I.

来源:J Trauma Acute Care Surg,查看原文。版权归原作者所有。

参考来源

  1. Reitz KM, Moore HB, Guyette FX, et al. Prehospital plasma in injured patients is associated with survival principally in blunt injury: Results from two randomized prehospital plasma trials. J Trauma Acute Care Surg. 2020. PMID: 31524836. doi:10.1097/TA.0000000000002485

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。